RAPP
Rapport Therapeutics, Inc. · Healthcare
Chief Operating Officer Cheryl Gault sold $416K of Rapport Therapeutics, Inc.
Sold$415,798
$41.58Price
10,000Shares
−6%Stake
What RAPP did after the filing
- The stock from Thu, Jul 2 open, $39.35
- +20.5%
- S&P 500, same days
- +3.9%
Measured over 30 trading days, to the Aug 14 close.
Traded Tue, Jun 30. Filed Wed, Jul 1, 4:10 PM ET, after the close. Returns use the Jul 2 open and the Aug 14 close. Not investment advice.